Hillhouse Capital Management Ltd. 13D and 13G filings for Legend Biotech Corporation:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-14 4:40 pm Sale | 2023-12-31 | 13G | Legend Biotech Corporation LEGN | Hillhouse Capital Management Ltd. | 13,052,732 3.600% | -7,220,502 (-35.62%) | Filing |
| 2023-02-14 4:12 pm Sale | 2022-12-31 | 13G | Legend Biotech Corporation LEGN | Hillhouse Capital Management Ltd. | 20,273,234 5.900% | -13,336,616 (-39.68%) | Filing |
| 2022-02-14 4:11 pm Purchase | 2021-12-31 | 13G | Legend Biotech Corporation LEGN | Hillhouse Capital Management Ltd. | 33,609,850 10.600% | 2,800,000 (+9.09%) | Filing |
| 2021-07-12 4:15 pm Purchase | 2021-05-31 | 13G | Legend Biotech Corporation LEGN | Hillhouse Capital Management Ltd. | 30,809,850 10.300% | 30,809,850 (New Position) | Filing |